Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, +359

The Lancet

VaccinationVaccine SafetyPhase 1/2Vaccine DevelopmentPreliminary Report +5

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients

Christoph Kreer, Matthias Zehner, Timm Weber, +25

Cell

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial

Pedro M. Folegatti, Mustapha Bittaye, Amy Flaxman, +27

The Lancet Infectious Diseases

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

Till Koch, Christine Dahlke, Anahita Fathi, +22

The Lancet Infectious Diseases

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

Naif Khalaf Alharbi, Eriko Padron-Regalado, Craig Thompson, +10

Vaccine

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

Asisa Volz, Alexandra Kupke, Fei Song, +8

Journal of Virology

A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform

Anna Malczyk, Alexandra Kupke, Steffen Prüfer, +20

Journal of Virology

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

Alina Tscherne, Jan Hendrik Schwarz, Cornelius Rohde, +26

Proceedings of the National Academy of Sciences

Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia

Kristina Dietert, Birgitt Gutbier, Sandra M. Wienhold, +20

PLoS ONE

Inflammatory Lung DiseaseModel-specific HistopathologiesLung InflammationPathogenesisImmunology +13

Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels

Naif Khalaf Alharbi, Ibrahim Qasim, Abdulrahman Almasoud, +22

Scientific Reports